$HQI
HireQuest, Inc.

2023 Q2 Form 10-Q Financial Statement

#000143774923013948 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $8.990M $9.857M
YoY Change -3.21% 21.02%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.625M $5.844M
YoY Change 59.35% 105.92%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $700.0K $697.0K
YoY Change 14.75% 23.14%
% of Gross Profit
Operating Expenses $5.625M $5.844M
YoY Change 35.87% 105.92%
Operating Profit $2.665M $3.316M
YoY Change -36.56% -16.66%
Interest Expense $314.0K $540.0K
YoY Change -670.91% 1025.0%
% of Operating Profit 11.78% 16.28%
Other Income/Expense, Net $99.00K $43.00K
YoY Change -93.21% -101.27%
Pretax Income $2.518M $2.865M
YoY Change -55.07% 344.19%
Income Tax $465.0K $547.0K
% Of Pretax Income 18.47% 19.09%
Net Earnings $2.008M $2.630M
YoY Change -58.95% 336.15%
Net Earnings / Revenue 22.34% 26.68%
Basic Earnings Per Share $0.15 $0.19
Diluted Earnings Per Share $0.15 $0.19
COMMON SHARES
Basic Shares Outstanding 13.90M 13.90M
Diluted Shares Outstanding 13.82M 13.78M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.071M $8.207M
YoY Change 83.6% 349.45%
Cash & Equivalents $2.071M $8.207M
Short-Term Investments
Other Short-Term Assets $3.599M $2.342M
YoY Change 42.31% -2.38%
Inventory
Prepaid Expenses $2.602M $1.426M
Receivables $51.09M $48.12M
Other Receivables $1.110M $967.0K
Total Short-Term Assets $57.87M $59.63M
YoY Change 13.85% 26.43%
LONG-TERM ASSETS
Property, Plant & Equipment $4.365M $4.388M
YoY Change -1.64% -2.1%
Goodwill $5.870M $5.870M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $142.0K $162.0K
YoY Change -91.46% -54.62%
Total Long-Term Assets $49.94M $50.92M
YoY Change 27.83% 33.48%
TOTAL ASSETS
Total Short-Term Assets $57.87M $59.63M
Total Long-Term Assets $49.94M $50.92M
Total Assets $107.8M $110.6M
YoY Change 19.93% 29.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $163.0K $207.0K
YoY Change -74.09% -78.39%
Accrued Expenses $4.619M $4.276M
YoY Change 93.99% 53.32%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $17.01M $21.71M
YoY Change 386.95% 249.97%
Total Short-Term Liabilities $40.60M $44.89M
YoY Change 41.71% 58.71%
LONG-TERM LIABILITIES
Long-Term Debt $348.0K $519.0K
YoY Change -90.45% -86.24%
Other Long-Term Liabilities $4.555M $4.532M
YoY Change -20.27% -23.51%
Total Long-Term Liabilities $4.903M $5.051M
YoY Change -47.61% 33.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $40.60M $44.89M
Total Long-Term Liabilities $4.903M $5.051M
Total Liabilities $45.76M $50.14M
YoY Change 20.4% 30.85%
SHAREHOLDERS EQUITY
Retained Earnings $28.51M $27.34M
YoY Change 69.01%
Common Stock $14.00K $14.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $62.05M $60.41M
YoY Change
Total Liabilities & Shareholders Equity $107.8M $110.6M
YoY Change 19.93% 29.58%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $2.008M $2.630M
YoY Change -58.95% 336.15%
Depreciation, Depletion And Amortization $700.0K $697.0K
YoY Change 14.75% 23.14%
Cash From Operating Activities -$618.0K $390.0K
YoY Change -116.98% -92.83%
INVESTING ACTIVITIES
Capital Expenditures $60.00K $159.0K
YoY Change -116.76% -165.16%
Acquisitions
YoY Change
Other Investing Activities $252.0K $196.0K
YoY Change -180.25% -102.17%
Cash From Investing Activities $192.0K $37.00K
YoY Change -128.57% -100.4%
FINANCING ACTIVITIES
Cash Dividend Paid $835.0K $833.0K
YoY Change 0.97% 1.34%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $2.977M
YoY Change 5516.98%
Cash From Financing Activities -5.710M $4.731M
YoY Change 55.76% 7.11%
NET CHANGE
Cash From Operating Activities -618.0K $390.0K
Cash From Investing Activities 192.0K $37.00K
Cash From Financing Activities -5.710M $4.731M
Net Change In Cash -6.136M $5.158M
YoY Change 779.08% 804.91%
FREE CASH FLOW
Cash From Operating Activities -$618.0K $390.0K
Capital Expenditures $60.00K $159.0K
Free Cash Flow -$678.0K $231.0K
YoY Change -116.96% -95.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
1405000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Intangible Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
3065000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13927000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13918000
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
40000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
40000
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss After Tax
ForeignCurrencyTransactionGainLossAfterTax
0 usd
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
13000
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
0
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
260000 usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-53088
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-2079472
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
111 Springhall Drive
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Goose Creek
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
SC
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
29445
CY2023Q1 dei City Area Code
CityAreaCode
843
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
723-7400
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
HQI
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13900000
CY2023Q1 us-gaap Cash
Cash
8207000 usd
CY2022Q4 us-gaap Cash
Cash
3049000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
48118000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45728000 usd
CY2023Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
967000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
817000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1426000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1833000 usd
CY2023Q1 hqi Prepaid Workers Compensation
PrepaidWorkersCompensation
916000 usd
CY2022Q4 hqi Prepaid Workers Compensation
PrepaidWorkersCompensation
503000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
59634000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
51930000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4388000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4353000 usd
CY2023Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1469000 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1231000 usd
CY2023Q1 us-gaap Indefinite Lived Franchise Rights
IndefiniteLivedFranchiseRights
22718000 usd
CY2022Q4 us-gaap Indefinite Lived Franchise Rights
IndefiniteLivedFranchiseRights
23144000 usd
CY2023Q1 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
10543000 usd
CY2022Q4 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
10690000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
5870000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
5870000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
162000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
325000 usd
CY2023Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
4363000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
2675000 usd
CY2023Q1 us-gaap Assets
Assets
110552000 usd
CY2022Q4 us-gaap Assets
Assets
103283000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
207000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
448000 usd
CY2023Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
21214000 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
12543000 usd
CY2023Q1 us-gaap Loans Payable Current
LoansPayableCurrent
498000 usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
704000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4169000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3408000 usd
CY2023Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4276000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
5602000 usd
CY2023Q1 hqi Due To Franchisees Current
DueToFranchiseesCurrent
10372000 usd
CY2022Q4 hqi Due To Franchisees Current
DueToFranchiseesCurrent
9846000 usd
CY2023Q1 hqi Risk Management Incentive Program Liability Current
RiskManagementIncentiveProgramLiabilityCurrent
1116000 usd
CY2022Q4 hqi Risk Management Incentive Program Liability Current
RiskManagementIncentiveProgramLiabilityCurrent
877000 usd
CY2023Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
3041000 usd
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
3352000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
44893000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
36780000 usd
CY2023Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
519000 usd
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
3291000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
195000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
60000 usd
CY2023Q1 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
2173000 usd
CY2022Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
2573000 usd
CY2023Q1 us-gaap Deposits
Deposits
2359000 usd
CY2022Q4 us-gaap Deposits
Deposits
2325000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
50139000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
45029000 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
14000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
14000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33206000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32844000 usd
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
146000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
146000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
27339000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
25542000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
60413000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
58254000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
110552000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
103283000 usd
CY2023Q1 us-gaap Revenues
Revenues
9857000 usd
CY2022Q1 us-gaap Revenues
Revenues
7043000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5844000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2655000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
697000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
499000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3316000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3889000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
43000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3379000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
46000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
94000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
540000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
48000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2865000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
556000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
547000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2318000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
491000 usd
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
312000 usd
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
112000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2630000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
603000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.17
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.04
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.02
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.17
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.04
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.02
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13707000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13526000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13782000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13659000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
58254000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
362000 usd
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
833000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2630000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
60413000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
46735000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
479000 usd
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
822000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
603000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
46995000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2630000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
603000 usd
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
312000 usd
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
112000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2318000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
491000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
697000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
499000 usd
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
328000 usd
CY2022Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
24000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
362000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
246000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
135000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-139000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-0 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-3625000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2390000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2634000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-372000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
359000 usd
CY2023Q1 hqi Increase Decrease In Prepaid Workers Compensation
IncreaseDecreaseInPrepaidWorkersCompensation
413000 usd
CY2022Q1 hqi Increase Decrease In Prepaid Workers Compensation
IncreaseDecreaseInPrepaidWorkersCompensation
791000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-241000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1577000 usd
CY2023Q1 hqi Increase Decrease In Risk Management Incentive Program Liability
IncreaseDecreaseInRiskManagementIncentiveProgramLiability
239000 usd
CY2022Q1 hqi Increase Decrease In Risk Management Incentive Program Liability
IncreaseDecreaseInRiskManagementIncentiveProgramLiability
92000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
760000 usd
CY2022Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
684000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-1326000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-819000 usd
CY2023Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
526000 usd
CY2022Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
711000 usd
CY2023Q1 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
238000 usd
CY2022Q1 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
283000 usd
CY2023Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-711000 usd
CY2022Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-98000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
418000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4940000 usd
CY2023Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-28000 usd
CY2022Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
503000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
390000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5443000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
-0 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
18470000 usd
CY2023Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
77000 usd
CY2022Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
81000 usd
CY2023Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 usd
CY2022Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
9317000 usd
CY2023Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
187000 usd
CY2022Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
95000 usd
CY2023Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
25000 usd
CY2022Q1 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
40000 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
82000 usd
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
163000 usd
CY2023Q1 hqi Net Change In Franchisee Deposits
NetChangeInFranchiseeDeposits
34000 usd
CY2022Q1 hqi Net Change In Franchisee Deposits
NetChangeInFranchiseeDeposits
52000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
37000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9290000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2977000 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
53000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
131000 usd
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
833000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
822000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4731000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4417000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5158000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
570000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3049000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1256000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8207000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1826000 usd
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
2000000 usd
CY2022Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
350000 usd
CY2023Q1 us-gaap Accounts Receivable Sale
AccountsReceivableSale
0 usd
CY2022Q1 us-gaap Accounts Receivable Sale
AccountsReceivableSale
2202000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
204000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
24000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-38000 usd
CY2023Q1 hqi Number Of Franchisee Owned Offices
NumberOfFranchiseeOwnedOffices
440 pure
CY2023Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
38 pure
CY2023Q1 hqi Number Of Employees
NumberOfEmployees
85000 pure
CY2023Q1 hqi Royalty Fees Percentage Of Payroll
RoyaltyFeesPercentageOfPayroll
0.045 pure
CY2023Q1 hqi Revenue Percentage Of Gross Margin
RevenuePercentageOfGrossMargin
0.180 pure
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9323000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss After Tax
ForeignCurrencyTransactionGainLossAfterTax
0 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. Actual results could differ from those estimates.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Significant estimates and assumptions underlie our workers’ compensation claim liabilities, our workers’ compensation Risk Management Incentive Program, our deferred taxes, our allowance for credit losses, potential impairment of goodwill and other intangibles, stock-based compensation, and estimated fair value of assets and liabilities acquired.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
84000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
70000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6575000 usd
CY2023Q1 hqi License Fee Percentage Of Gross Margin
LicenseFeePercentageOfGrossMargin
0.090 pure
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
260000 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
31131000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3676000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
27455000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
31050000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3022000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
28028000 usd
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
36937000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3676000 usd
CY2023Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
33261000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
36856000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3022000 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
33834000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
5870000 usd
CY2023Q1 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 usd
CY2023Q1 us-gaap Goodwill
Goodwill
5870000 usd
CY2023Q1 hqi Common Equivalent Shares Outstanding
CommonEquivalentSharesOutstanding
192000
CY2022Q1 hqi Common Equivalent Shares Outstanding
CommonEquivalentSharesOutstanding
267000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13707000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13526000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
75000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
133000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13782000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13659000
CY2023Q1 hqi Number Of Offices
NumberOfOffices
437 pure
CY2021Q2 us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.0025 pure
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.47
CY2022Q4 hqi Sharebased Compensation Arrangement By Sharebased Payment Award Option Outstanding Weighted Average Exercise Price Ending Balance
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionOutstandingWeightedAverageExercisePriceEndingBalance
2980 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2014Q1 hqi Insurance Collateral Deposits
InsuranceCollateralDeposits
9200000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.06
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
822000 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.06
CY2022Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
827000 usd
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.06
CY2022Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
829000 usd
CY2022Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.06
CY2022Q4 us-gaap Payments Of Dividends
PaymentsOfDividends
833000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.06
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
833000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
13000
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.47
CY2023Q1 hqi Sharebased Compensation Arrangement By Sharebased Payment Award Option Outstanding Weighted Average Exercise Price Ending Balance
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionOutstandingWeightedAverageExercisePriceEndingBalance
2980 pure
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
0
CY2023Q1 us-gaap Share Price
SharePrice
21.57
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.47
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
208000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1700000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y7M6D
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.191 pure
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.117 pure
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2023Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
17000 usd
CY2022Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
36000 usd
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
5200000 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
2400000 usd
CY2023Q1 us-gaap Interest Income Operating
InterestIncomeOperating
46000 usd
CY2022Q1 us-gaap Interest Income Operating
InterestIncomeOperating
93000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
260000 usd

Files In Submission

Name View Source Status
0001437749-23-013948-index-headers.html Edgar Link pending
0001437749-23-013948-index.html Edgar Link pending
0001437749-23-013948.txt Edgar Link pending
0001437749-23-013948-xbrl.zip Edgar Link pending
ex_462684.htm Edgar Link pending
ex_462685.htm Edgar Link pending
ex_462686.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hqi-20230331.xsd Edgar Link pending
hqi20230331_10q.htm Edgar Link pending
image01.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
hqi-20230331_cal.xml Edgar Link unprocessable
hqi-20230331_def.xml Edgar Link unprocessable
hqi-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
hqi-20230331_pre.xml Edgar Link unprocessable
hqi20230331_10q_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending